Screening for active cutaneous porphyria can be achieved by blood porphyrin screen alone. However, urine and faecal porphyrin analysis may be required to distinguish between certain cutaneous porphyrias and to support subsequent monitoring of treatment. It may therefore be more cost effective to send urine and EDTA blood for frontline testing.